Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Predicting up to 10 year breast cancer risk using longitudinal mammographic screening history

Xin Wang, Tao Tan, Yuan Gao, Ruisheng Su, Tianyu Zhang, Luyi Han, Jonas Teuwen, Anna D’Angelo, Caroline A. Drukker, Marjanka K. Schmidt, Regina Beets-Tan, Nico Karssemeijer, Ritse Mann
doi: https://doi.org/10.1101/2023.06.28.23291994
Xin Wang
1Department of Radiology, The Netherlands Cancer Institute, Amsterdam, 1066 CX, The Netherlands
2GROW School, Maastricht University, Maastricht, 6202 AZ, The Netherlands
3Department of Radiology and Nuclear Medicine, Radboud University Medical Centre, Nijmegen, 6525 GA, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tao Tan
1Department of Radiology, The Netherlands Cancer Institute, Amsterdam, 1066 CX, The Netherlands
4Faculty of Applied Sciences, Macao Polytechnic University, Macao SAR, 999078, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: taotanjs{at}gmail.com
Yuan Gao
1Department of Radiology, The Netherlands Cancer Institute, Amsterdam, 1066 CX, The Netherlands
2GROW School, Maastricht University, Maastricht, 6202 AZ, The Netherlands
3Department of Radiology and Nuclear Medicine, Radboud University Medical Centre, Nijmegen, 6525 GA, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ruisheng Su
5Erasmus Medical Center, Erasmus University, Rotterdam, 3015 GD, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tianyu Zhang
1Department of Radiology, The Netherlands Cancer Institute, Amsterdam, 1066 CX, The Netherlands
2GROW School, Maastricht University, Maastricht, 6202 AZ, The Netherlands
3Department of Radiology and Nuclear Medicine, Radboud University Medical Centre, Nijmegen, 6525 GA, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Luyi Han
1Department of Radiology, The Netherlands Cancer Institute, Amsterdam, 1066 CX, The Netherlands
3Department of Radiology and Nuclear Medicine, Radboud University Medical Centre, Nijmegen, 6525 GA, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jonas Teuwen
6Department of Radiation Oncology, The Netherlands Cancer Institute, Amsterdam, 1066 CX, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anna D’Angelo
1Department of Radiology, The Netherlands Cancer Institute, Amsterdam, 1066 CX, The Netherlands
7Dipartimento di Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia, Fondazione Policlinico Universitario A. Gemelli,IRCCS, 00168 Rome, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Caroline A. Drukker
8Department of Surgical Oncology, The Netherlands Cancer Institute, Amsterdam, 1066 CX, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marjanka K. Schmidt
9Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, 1066 CX, The Netherlands
10Department of Epidemiology, The Netherlands Cancer Institute, Amsterdam, 1066 CX, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Regina Beets-Tan
1Department of Radiology, The Netherlands Cancer Institute, Amsterdam, 1066 CX, The Netherlands
2GROW School, Maastricht University, Maastricht, 6202 AZ, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nico Karssemeijer
11Department of Medical Imaging, Radboud University Medical Center, Nijmegen, 6500 HB, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ritse Mann
1Department of Radiology, The Netherlands Cancer Institute, Amsterdam, 1066 CX, The Netherlands
3Department of Radiology and Nuclear Medicine, Radboud University Medical Centre, Nijmegen, 6525 GA, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Risk assessment of breast cancer (BC) seeks to enhance individualized screening and prevention strategies. BC risk informs healthy individuals of the short- and long-term likelihood of cancer development, also enabling detection of existing BC. Recent mammographic-based deep learning (DL) risk models outperform traditional risk factor-based models and achieve state-of-the-art (SOTA) at short-term risk prediction, but mainly use single-time exams, which seem to rely more on detecting existing lesions. We present a novel temporospatial and explainable deep learning risk model, the Multi-Time Point Breast Cancer Risk Model (MTP-BCR), which learns from longitudinal mammography data to identify subtle changes in breast tissue that may signal future malignancy. Utilizing a large in-house dataset of 171,168 screening mammograms from 42,792 consecutive exams involving 9,133 women, our model demonstrates a significant improvement in long-term (10-year) risk prediction with an area under the receiver operating characteristics (AUC) of 0.80, outperforming the traditional BCSC 10-year risk model and other SOTA methods at 5-year AUC in various screening cohorts. Furthermore, MTP-BCR provides unilateral breast-level predictions, achieving AUCs up to 0.81 and 0.77 for 5-year risk and 10-year risk assessments, respectively. The heatmaps derived from our model may help clinicians better understand the progression from normal tissue to cancerous growth, enhancing interpretability in breast cancer risk assessment.

Teaser MTP-BCR model uses multi-time points mammograms and rich risk factors to predict 10-year breast cancer risk more accurately.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This study was funded by Chinese Scholarship Council scholarship (CSC)

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

This study was approved by the Netherlands Cancer Institute(NKI) institutional review board.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes

Data Availability

The inhouse dataset is used under license to the respective hospital system for the current study and is not publicly available.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted June 29, 2023.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Predicting up to 10 year breast cancer risk using longitudinal mammographic screening history
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Predicting up to 10 year breast cancer risk using longitudinal mammographic screening history
Xin Wang, Tao Tan, Yuan Gao, Ruisheng Su, Tianyu Zhang, Luyi Han, Jonas Teuwen, Anna D’Angelo, Caroline A. Drukker, Marjanka K. Schmidt, Regina Beets-Tan, Nico Karssemeijer, Ritse Mann
medRxiv 2023.06.28.23291994; doi: https://doi.org/10.1101/2023.06.28.23291994
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Predicting up to 10 year breast cancer risk using longitudinal mammographic screening history
Xin Wang, Tao Tan, Yuan Gao, Ruisheng Su, Tianyu Zhang, Luyi Han, Jonas Teuwen, Anna D’Angelo, Caroline A. Drukker, Marjanka K. Schmidt, Regina Beets-Tan, Nico Karssemeijer, Ritse Mann
medRxiv 2023.06.28.23291994; doi: https://doi.org/10.1101/2023.06.28.23291994

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Radiology and Imaging
Subject Areas
All Articles
  • Addiction Medicine (349)
  • Allergy and Immunology (668)
  • Allergy and Immunology (668)
  • Anesthesia (181)
  • Cardiovascular Medicine (2648)
  • Dentistry and Oral Medicine (316)
  • Dermatology (223)
  • Emergency Medicine (399)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
  • Epidemiology (12228)
  • Forensic Medicine (10)
  • Gastroenterology (759)
  • Genetic and Genomic Medicine (4103)
  • Geriatric Medicine (387)
  • Health Economics (680)
  • Health Informatics (2657)
  • Health Policy (1005)
  • Health Systems and Quality Improvement (985)
  • Hematology (363)
  • HIV/AIDS (851)
  • Infectious Diseases (except HIV/AIDS) (13695)
  • Intensive Care and Critical Care Medicine (797)
  • Medical Education (399)
  • Medical Ethics (109)
  • Nephrology (436)
  • Neurology (3882)
  • Nursing (209)
  • Nutrition (577)
  • Obstetrics and Gynecology (739)
  • Occupational and Environmental Health (695)
  • Oncology (2030)
  • Ophthalmology (585)
  • Orthopedics (240)
  • Otolaryngology (306)
  • Pain Medicine (250)
  • Palliative Medicine (75)
  • Pathology (473)
  • Pediatrics (1115)
  • Pharmacology and Therapeutics (466)
  • Primary Care Research (452)
  • Psychiatry and Clinical Psychology (3432)
  • Public and Global Health (6527)
  • Radiology and Imaging (1403)
  • Rehabilitation Medicine and Physical Therapy (814)
  • Respiratory Medicine (871)
  • Rheumatology (409)
  • Sexual and Reproductive Health (410)
  • Sports Medicine (342)
  • Surgery (448)
  • Toxicology (53)
  • Transplantation (185)
  • Urology (165)